These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36959454)

  • 1. Homology Modeling of Antibody Variable Regions: Methods and Applications.
    Bansia H; Ramakumar S
    Methods Mol Biol; 2023; 2627():301-319. PubMed ID: 36959454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiotope determining regions of a mouse monoclonal antibody and its humanized versions. Identification of framework residues that affect idiotype expression.
    Corti A; Barbanti E; Tempest PR; Carr FJ; Marcucci F
    J Mol Biol; 1994 Jan; 235(1):53-60. PubMed ID: 8289265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction.
    Zhu K; Day T; Warshaviak D; Murrett C; Friesner R; Pearlman D
    Proteins; 2014 Aug; 82(8):1646-55. PubMed ID: 24619874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antibody CDR loops change conformation upon binding?
    Liu C; Denzler LM; Hood OEC; Martin ACR
    MAbs; 2024; 16(1):2322533. PubMed ID: 38477253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and modeling of the variable region of camelid single-domain antibodies.
    Sircar A; Sanni KA; Shi J; Gray JJ
    J Immunol; 2011 Jun; 186(11):6357-67. PubMed ID: 21525384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for the homology modeling of antibody variable regions.
    Sircar A
    Methods Mol Biol; 2012; 857():301-11. PubMed ID: 22323227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
    Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
    Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of the CDR Loops of Antigen Receptors.
    Wong WK; Leem J; Deane CM
    Front Immunol; 2019; 10():2454. PubMed ID: 31681328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new clustering of antibody CDR loop conformations.
    North B; Lehmann A; Dunbrack RL
    J Mol Biol; 2011 Feb; 406(2):228-56. PubMed ID: 21035459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region.
    Keck PC; Huston JS
    Biophys J; 1996 Oct; 71(4):2002-11. PubMed ID: 8889174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Comparative Modeling of V
    Vattekatte AM; Cadet F; Gelly JC; de Brevern AG
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational approach for studying antibody-antigen interactions without prior structural information: the anti-testosterone binding antibody as a case study.
    Koivuniemi A; Takkinen K; Nevanen T
    Proteins; 2017 Feb; 85(2):322-331. PubMed ID: 27936519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking.
    Sivasubramanian A; Sircar A; Chaudhury S; Gray JJ
    Proteins; 2009 Feb; 74(2):497-514. PubMed ID: 19062174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.